A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Aichi, 456-0058, Japan

Chiba, 263-0043, Japan

Ehime, 790-0067, Japan

Ehime, 792-0045, Japan

Ehime, 792-8586, Japan

Fukuoka, 810-0014, Japan

Fukuoka, 812-0053, Japan

Fukuoka, 815-8588, Japan

Fukuoka, 819-0168, Japan

Fukushima, 960-0418, Japan

Fukushima, 961-0416, Japan

Fukushima, 963-8851, Japan

Fukushima, 964-8501, Japan

Gunma, 370-3573, Japan

Gunma, 379-0116, Japan

Hiroshima, 731-0103, Japan

Hokkaido, 040-8585, Japan

Hokkaido, 062-0007, Japan

Hokkaido, 070-0002, Japan

Hokkaido, 072-0012, Japan

Hokkaido, 080-0010, Japan

Hokkaido, 080-0016, Japan

Hyōgo, 670-0074, Japan

Ibaraki, 300-0835, Japan

Ibaraki, 300-1512, Japan

Ibaraki, 311-0113, Japan

Kagawa, 760-0017, Japan

Kagawa, 760-0076, Japan

Kagoshima, 890-0061, Japan

Kanagawa, 212-0024, Japan

Kanagawa, 232-0064, Japan

Kanagawa, 235-0045, Japan

Kanagawa, 238-0011, Japan

Kanagawa, 242-0004, Japan

Kanagawa, 253-0044, Japan

Kochi, 780-0088, Japan

Kumamoto, 862-0976, Japan

Kumamoto, 866-8660, Japan

Kumamoto, 867-0041, Japan

Kyoto, 600-8558, Japan

Kyoto, 601-1495, Japan

Miyagi, 980-0021, Japan

Miyagi, 985-0852, Japan

Nagano, 385-0022, Japan

Nagano, 399-0006, Japan

Nagano, 399-0036, Japan

Nara, 634-0007, Japan

Okinawa, 901-0243, Japan

Osaka, 530-0001, Japan

Osaka, 530-0004, Japan

Osaka, 530-0012, Japan

Osaka, 532-0026, Japan

Osaka, 536-0023, Japan

Osaka, 538-0044, Japan

Osaka, 577-0803, Japan

Ōita, 870-0039, Japan

Ōita, 876-0851, Japan

Saitama, 332-0012, Japan

Saitama, 350-0035, Japan

Saitama, 350-0851, Japan

Saitama, 354-0031, Japan

Saitama, 355-0321, Japan

Saitama, 358-0011, Japan

Shizuoka, 424-0855, Japan

Tochigi, 329-0433, Japan

Tokyo, 103-0002, Japan

Tokyo, 103-0027, Japan

Tokyo, 103-0028, Japan

Tokyo, 104-0031, Japan

Tokyo, 104-0061, Japan

Tokyo, 125-0054, Japan

Tokyo, 136-0073, Japan

Tokyo, 143-0015, Japan

Yamaguchi, 755-0047, Japan